BIVALIRUDIN VERSUS HEPARIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE: INSIGHTS FROM META-ANALYSIS OF RANDOMIZED TRIALS

Chirag Bavishi,Vrinda Trivedi,Saurav Chatterjee, J. Abbott,Herbert D. Aronow,Gregg W. Stone,Sripal Bangalore

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2018）

引用 1|浏览10

暂无评分

摘要

Chronic kidney disease (CKD) is associated with an increased risk of ischemic and bleeding events in patients undergoing percutaneous coronary intervention (PCI). The pharmacological properties of bivalirudin may be of particular benefit in this high-risk subgroup.Electronic databases were

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要